Understanding Schizophrenia as a Disorder of Consciousness: Biological Correlates and Translational Implications from Quantum Theory Perspectives

다국어 초록 (Multilingual Abstract)

From neurophenomenological perspectives, schizophrenia has been conceptualized as “a disorder with heterogeneous manifestations that can be integrally understood to involve fundamental perturbations in consciousness”. While these theoretical constructs based on consciousness facilitate understanding the ‘gestalt’ of schizophrenia, systematic research to unravel translational implications of these models is warranted. To address this, one needs to begin with exploration of plausible biological underpinnings of “perturbed consciousness” in schizophrenia. In this context, an attractive proposition to understand the biology of consciousness is “the orchestrated object reduction (Orch-OR) theory” which invokes quantum processes in the microtubules of neurons. The Orch-OR model is particularly important for understanding schizophrenia especially due to the shared ‘scaffold’ of microtubules. The initial sections of this review focus on the compelling evidence to support the view that “schizophrenia is a disorder of consciousness” through critical summary of the studies that have demonstrated self-abnormalities, aberrant time perception as well as dysfunctional intentional binding in this disorder. Subsequently, these findings are linked with ‘Orch-OR theory’ through the research evidence for aberrant neural oscillations as well as microtubule abnormalities observed in schizophrenia. Further sections emphasize the applicability and translational implications of Orch-OR theory in the context of schizophrenia and elucidate the relevance of quantum biology to understand the origins of this puzzling disorder as “fundamental disturbances in consciousness”.

참고문헌 (Reference)

1 Garey L., "When cortical development goes wrong : schizophrenia as a neurodevelopmental disease of microcircuits" 217 : 324-333, 2010

2 Buhusi CV., "What makes us tick? Functional and neural mechanisms of interval timing" 6 : 755-765, 2005

3 Miller G., "What is the biological basis of consciousness?" 309 : 79-, 2005

4 Haggard P., "Voluntary action and conscious awareness" 5 : 382-385, 2002

5 Hameroff S., "Transcranial ultrasound(TUS)effects on mental states : a pilot study" 6 : 409-415, 2013

6 Legon W., "Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans" 17 : 322-329, 2014

7 Mueller J., "Transcranial focused ultrasound modulates intrinsic and evoked EEG dynamics" 7 : 900-908, 2014

8 Gómez J., "Time perception networks and cognition in schizophrenia : A review and a proposal" 220 : 737-744, 2014

9 Waters F., "Time discrimination deficits in schizophrenia patients with first-rank(passivity)symptoms" 167 : 12-20, 2009

10 Fleck JI., "The transliminal brain at rest : baseline EEG, unusual experiences, and access to unconscious mental activity" 44 : 1353-1363, 2008

11 Andrieux A., "The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders" 16 : 2350-2364, 2002

12 Maj M., "The self and schizophrenia : some open issues" 11 : 65-66, 2012

13 Uhlhaas PJ., "The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia" 34 : 927-943, 2008

14 Lange R., "The revised transliminality scale : reliability and validity data from a Rasch top-down purification procedure" 9 : 591-617, 2000

15 Selemon LD., "The reduced neuropil hypothesis : a circuit based model of schizophrenia" 45 : 17-25, 1999

16 Harrison PJ., "The neuropathological effects of antipsychotic drugs" 40 : 87-99, 1999

17 Benitez-King G., "The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia" 3 : 515-533, 2004

18 Tamminga CA., "The hippocampal formation in schizophrenia" 167 : 1178-1193, 2010

19 Tuszynski JA., "The emerging physics of consciousness" Springer-Verlag 1-26, 2006

20 Hur JW., "The crisis of minimal self-awareness in schizophrenia : a meta-analytic review" 152 : 58-64, 2014

21 Parnas J., "The core Gestalt of schizophrenia" 11 : 67-69, 2012

22 Venkatasubramanian G., "The TRIPS(toll-like receptors in immuno-inflammatory pathogenesis)hypothesis : a novel postulate to understand schizophrenia" 44 : 301-311, 2013

23 Papageorgiou C., "Temporal processing dysfunction in schizophrenia as measured by time interval discrimination and tempo reproduction tasks" 40 : 173-179, 2013

24 Spellman TJ., "Synchrony in schizophrenia: a window into circuit-level pathophysiology" 30C : 17-23, 2014

25 Venkatasubramanian G., "Striato-cerebellar abnormalities in never-treated schizophrenia : evidence for neurodevelopmental etiopathogenesis" 6 : 1-7, 2003

26 Hauser M., "Sense of agency is altered in patients with a putative psychotic prodrome" 126 : 20-27, 2011

27 Sass LA., "Self-disturbance and schizophrenia : structure, specificity, pathogenesis(current issues, new directions)" 152 : 5-11, 2014

28 Sass LA., "Schizophrenia, consciousness, and the self" 29 : 427-444, 2003

29 Keshavan MS., "Schizophrenia, "Just the Facts"6. Moving ahead with the schizophrenia concept : from the elephant to the mouse" 127 : 3-13, 2011

30 Carter CJ., "Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens : cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii" 35 : 1163-1182, 2009

31 Venkatasubramanian G., "Schizophrenia is a disorder of aberrant neurodevelopment : A synthesis of evidence from clinical and structural, functional and neurochemical brain imaging studies" 49 : 244-249, 2007

32 Harrison PJ., "Schizophrenia genes, gene expression, and neuropathology : on the matter of their convergence" 10 : 40-68, 2005

33 Crow TJ., "Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease" 46 : 1145-1150, 1989

34 Howes OD., "Schizophrenia : an integrated sociodevelopmental-cognitive model" 383 : 1677-1687, 2014

35 van Os J., "Schizophrenia" 374 : 635-645, 2009

36 Cantero JL., "Role of tau protein on neocortical and hippocampal oscillatory patterns" 21 : 827-834, 2011

37 Avila J., "Role of tau protein in both physiological and pathological conditions" 84 : 361-384, 2004

38 Costas J., "Role of DISC1 interacting proteins in schizophrenia risk from genome-wide analysis of missense SNPs" 77 : 504-512, 2013

39 Mitchell RL., "Right hemisphere language functions and schizophrenia : the forgotten hemisphere?" 128 : 963-978, 2005

40 Insel TR., "Rethinking schizophrenia" 468 : 187-193, 2010

41 Northoff G., "Resting state activity and the"stream of consciousness"in schizophrenia-neurophenomenal hypotheses" 41 : 280-290, 2015

42 Kalmady SV., "Relationship between brainderived neurotrophic factor and schneiderian first rank symptoms in antipsychotic-naïve schizophrenia" 4 : 64-, 2013

43 Thalbourne MA., "Relation between transliminality and openness to experience" 86 : 909-910, 2000

44 Venkatasubramanian G., "Reformulating schizophrenia : the importance of evolutionary theories" 72 : 229-230, 2009

45 Volle J., "Reduced expression of STOP/MAP6 in mice leads to cognitive deficits" 39 : 969-978, 2013

46 Debnath M., "Recent advances in psychoneuroimmunology relevant to schizophrenia therapeutics" 26 : 433-439, 2013

47 Chopra D., "Reality and consciousness: a view from the East: comment on "Consciousness in the universe: a review of the 'Orch OR' theory" by Stuart Hameroff and Roger Penrose" 11 : 81-82, 2014

48 Fleming GR., "Quantum effects in biology" 3 : 38-57, 2011

49 Lambert N., "Quantum biology" 9 : 10-18, 2013

50 Werneke U., "Psychiatry and reality. Perception of matter or matter of perception?" 9 : 190-201, 2011

51 Persinger MA., "Protracted parahippocampal activity associated with Sean Harribance" 5 : 140-145, 2012

52 Kaiser J., "Prefrontal gamma-band activity distinguishes between sound durations" 1139 : 153-162, 2007

53 Fernandes BS, "Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications" 2014

54 Allman MJ., "Pathophysiological distortions in time perception and timed performance" 135 : 656-677, 2012

55 Buttrick GJ., "PI3-K and GSK-3 : Akt-ing together with microtubules" 7 : 2621-2625, 2008

56 Woolf NJ., "Neuropsychiatric illness : a case for impaired neuroplasticity and possible quantum processing derailment in microtubules" 8 : 13-28, 2010

57 Balu DT., "Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia" 35 : 848-870, 2011

58 Ganesan Venkatasubramanian, "Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis" 대한정신약물학회 12 (12): 8-18, 2014

59 Lepage M., "Neurocognition : clinical and functional outcomes in schizophrenia" 59 : 5-12, 2014

60 Coull JT., "Neuroanatomical and neurochemical substrates of timing" 36 : 3-25, 2011

61 Varela FJ., "Naturalizing phenomenology. Issues in contemporary phenomenology and cognitive science" Stanford University Press 266-314, 1999

62 Gonzalez-Burgos G., "NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia" 38 : 950-957, 2012

63 Synofzik M., "Misattributions of agency in schizophrenia are based on imprecise predictions about the sensory consequences of one's actions" 133 : 262-271, 2010

64 Gozes I., "Microtubules, schizophrenia and cognitive behavior : preclinical development of davunetide(NAP)as a peptide-drug candidate" 32 : 428-431, 2011

65 Andrieux A., "Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia" 60 : 1224-1230, 2006

66 Conde C., "Microtubule assembly, organization and dynamics in axons and dendrites" 10 : 319-332, 2009

67 Hughes G., "Mechanisms of intentional binding and sensory attenuation : the role of temporal prediction, temporal control, identity prediction, and motor prediction" 139 : 133-151, 2013

68 Thalbourne MA., "Measures of the sheep-goat variable, transliminality, and their correlates" 88 : 339-350, 2001

69 Brandon NJ., "Linking neurodevelopmental and synaptic theories of mental illness through DISC1" 12 : 707-722, 2011

70 Coull JT., "Ketamine perturbs perception of the flow of time in healthy volunteers" 218 : 543-556, 2011

71 Moore JW., "Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia" 16 : 364-381, 2011

72 Craddock TJ., "Keeping time : could quantum beating in microtubules be the basis for the neural synchrony related to consciousness?" 13 : 293-311, 2014

73 Crow TJ., "Is schizophrenia the price that Homo sapiens pays for language?" 28 : 127-141, 1997

74 Venkatasubramanian G., "Investigating paranormal phenomena : Functional brain imaging of telepathy" 1 : 66-71, 2008

75 Moore JW., "Intentional binding and the sense of agency : a review" 21 : 546-561, 2012

76 Faber J., "Information processing in brain microtubules" 83 : 1-9, 2006

77 Subburaju S., "Induction of the GABA cell phenotype : an in vitro model for studying neurodevelopmental disorders" 7 : e33352-, 2012

78 Thyberg J., "In vitro effects of chlorpromazine on microtubules and the Golgi complex in embryonic chick spinal ganglion cells : an electron microscopic study" 137 : 323-332, 1977

79 Eisenberg DP., "Hippocampal dysfunction in schizophrenia : association with brain-derived neurotrophic factor genotype" 18 : 631-, 2013

80 Anthony A. Grace, "Hippocampal Dysregulation of Dopamine System Activity as a Pathophysiological Basis for Psychosis in Schizophrenia" 대한정신약물학회 8 (8): 1-9, 2010

81 Uhlhaas PJ., "High-frequency oscillations and the neurobiology of schizophrenia" 15 : 301-313, 2013

82 Corlett PR., "Glutamatergic model psychoses : prediction error, learning, and inference" 36 : 294-315, 2011

83 Zhang Y., "Exploratory quantum resonance spectrometer as a discriminator for psychiatric affective disorders" 202 : 287-291, 2014

84 Frith C., "Explaining delusions of control : the comparator model 20 years on" 21 : 52-54, 2012

85 Ghosh S., "Evidence of massive global synchronization and the consciousness: comment on "Consciousness in the universe: a review of the 'Orch OR' theory" by Hameroff and Penrose" 11 : 83-84, 2014

86 Wilson TW., "Estimating the passage of minutes : deviant oscillatory frontal activity in medicated and unmedicated ADHD" 27 : 654-665, 2013

87 Jarskog LF., "Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia" 38 : 1245-1252, 2013

88 Javitt DC., "Effect of the neuroprotective peptide davunetide(AL-108)on cognition and functional capacity in schizophrenia" 136 : 25-31, 2012

89 Deutsch SI., "Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications" 30 : 1369-1380, 2006

90 Stephan KE., "Dysconnection in schizophrenia : from abnormal synaptic plasticity to failures of self-monitoring" 35 : 509-527, 2009

91 Merriam EB., "Dynamic microtubules promote synaptic NMDA receptor-dependent spine enlargement" 6 : e27688-, 2011

92 Brun P., "Dopaminergic transmission in STOP null mice" 94 : 63-73, 2005

93 Moore JW., "Dopaminergic medication boosts action-effect binding in Parkinson's disease" 48 : 1125-1132, 2010

94 Vogeley K., "Disturbances of time consciousness from a phenomenological and a neuroscientific perspective" 33 : 157-165, 2007

95 Nelson B., "Disturbance of minimal self(ipseity)in schizophrenia : clarification and current status" 40 : 479-482, 2014

96 Craddock TJ., "Cytoskeletal signaling : is memory encoded in microtubule lattices by CaMKII phosphorylation?" 8 : e1002421-, 2012

97 Leonhard D., "Creative, paranormal, and delusional thought : a consequence of right hemisphere semantic activation?" 11 : 177-183, 1998

98 Matell MS., "Cortico-striatal circuits and interval timing : coincidence detection of oscillatory processes" 21 : 139-170, 2004

99 Jiang Z., "Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia" 7 : 116-, 2013

100 Hameroff S., "Consciousness in the universe : a review of the ‘Orch OR’ theory" 11 : 39-78, 2014

101 Bose A., "Cognitive mapping deficits in schizophrenia : a critical overview" 36 : 9-26, 2014

102 Henriksen MG., "Clinical manifestations of self-disorders and the Gestalt of schizophrenia" 38 : 657-660, 2012

103 Lisman JE., "Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia" 31 : 234-242, 2008

104 Pei Q., "Changes in mRNA abundance of microtubule-associated proteins in the rat brain following electroconvulsive shock" 9 : 391-394, 1998

105 Green MJ., "Brain-derived neurotrophic factor levels in schizophrenia : a systematic review with meta-analysis" 16 : 960-972, 2011

106 Northoff G., "Brain and self-a neurophilosophical account" 7 : 28-, 2013

107 Panja D., "BDNF mechanisms in late LTP formation: a synthesis and breakdown" 76 (76): 664-676, 2014

108 Haggard P., "Awareness of action in schizophrenia" 14 : 1081-1085, 2003

109 Moore J., "Awareness of action : Inference and prediction" 17 : 136-144, 2008

110 Sahu S., "Atomic water channel controlling remarkable properties of a single brain microtubule : correlating single protein to its supramolecular assembly" 47 : 141-148, 2013

111 Bonnot O., "Are impairments of time perception in schizophrenia a neglected phenomenon?" 105 : 164-169, 2011

112 Ford JM., "Anticipating the future : automatic prediction failures in schizophrenia" 83 : 232-239, 2012

113 Franck N., "Altered subjective time of events in schizophrenia" 193 : 350-353, 2005

114 Voss M., "Altered awareness of action in schizophrenia : a specific deficit in predicting action consequences" 133 : 3104-3112, 2010

115 Uhlhaas PJ., "Abnormal neural oscillations and synchrony in schizophrenia" 11 : 100-113, 2010

116 Arnold SE., "Abnormal expression of two microtubule-associated proteins(MAP2 and MAP5)in specific subfields of the hippocampal formation in schizophrenia" 88 : 10850-10854, 1991

117 Taylor JG., "A neural model of the loss of self in schizophrenia" 37 : 1229-1247, 2011

118 Rizig MA., "A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia" 26 : 1218-1230, 2012

119 Boley AM., "A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia" 157 : 238-243, 2014

120 Parnas J., "A disappearing heritage : the clinical core of schizophrenia" 37 : 1121-1130, 2011

121 Andreasen NC., ""Cognitive dysmetria"as an integrative theory of schizophrenia : a dysfunction in cortical-subcortical-cerebellar circuitry?" 24 : 203-218, 1998